Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study

Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study

<p>Abstract</p> <p>Background</p> <p>A considerable number of patients with severely elevated LDL-C do not achieve recommended treatment targets, despite treatment with statins. Adults at high cardiovascular risk with hypercholesterolemia and LDL-C ≥ 2.59 and ≤ 4.14 mmo...

Full description

Bibliographic Details
Main Authors: Hing Ling Paul, Civeira Fernando, Dan Andrei, Hanson Mary E, Massaad Rachid, De Tilleghem Celine, Milardo Christopher, Triscari Joseph
Format: Article
Language:English
Published: BMC 2012-01-01
Series:Lipids in Health and Disease
Subjects:
Ezetimibe/simvastatin
Atorvastatin
High cardiovascular risk
Primary hypercholesterolemia
Lipid-lowering
Online Access:http://www.lipidworld.com/content/11/1/18

Internet

http://www.lipidworld.com/content/11/1/18

Similar Items